期刊文献+

OsteopontinRNAi对人乳腺癌细胞MDA—MB-231生物学行为的影响

Effect of RNA interference for OPN on MDA-MB-231 cells and the growth of transplanted tumor in nude mice
原文传递
导出
摘要 目的观察乳腺癌细胞MDA—MB-231 osteopontin(OPN)RNA靶向干扰效果。方法采用OPNmRNA干扰质粒转染MDA-MB-231细胞,建立OPN基因沉默细胞株,采用RT-PCR、蛋白质印迹法从mRNA和蛋白水平检测乳腺癌细胞OPN表达量的变化,侵袭试验检测OPN下调对细胞侵袭能力的影响,MTT法测细胞增殖能力的改变,裸鼠成瘤后观察OPNRNA干扰对肿瘤细胞生长的影响及对移植瘤乏氧程度的影响。结果与MDA—MB-231细胞相比,OPN沉默细胞在常氧和乏氧状态下OPN表达均显著下调(均P〈0.05),OPN稳定沉默细胞侵袭力和增殖能力下降(均P〈0.01),OPNRNAi能明显抑制裸鼠移植瘤的生长(P〈0.05),且移植瘤内乏氧程度降低(P〈0.05)。结论OPNRNA干扰可抑制乳腺癌细胞MDA—MB-231细胞侵袭力和增殖能力,降低移植瘤的乏氧程度。 Objective To investigate the role of OPN in human breast cancer cell line ( MDA-MB- 231 ) by using small interfering RNA to specifically knockdown OPN expression. Methods OPN ShRNA expression vector was stably transfected to MDA-MB-231 cell line. The expression of OPN mRNA and protein were analyzed using reverse transcription polymerase chain reaction (RT-PCR) and Western blot, respectively. The growth of MDA-MB-231 cells were observed by MTF. The effect of OPN siRNA on the transplanted tumor growth and tumor hypoxia were assessed in nude mice. Results The expression level of OPN in MDA-MB-231 cells were significantly lower under hypoxia or normoxia( P 〈 0. 05 ). OPN silence with RNAi significantly inhibited the invasion ability and proliferation of MDA-MB-231 cell lines ( P 〈 0. 01 ). Inhibition of OPN with RNAi significantly inhibited the growth ability of MDA-MB-231 cells in vivo(P 〈 0. 05). The tumor hypoxia significantly decreased(P 〈 0.05). Conclusions OPN silence with RNAi can effectively inhibit cell proliferation and tumor growth of MDA-MB-231 cells, and decrease the bypoxia level of MDA-MB-231 transplanted tumor in nude mice.
出处 《中华普通外科杂志》 CSCD 北大核心 2012年第4期322-325,共4页 Chinese Journal of General Surgery
基金 山东省自然基金项目(Y2008C167)
关键词 乳腺肿瘤 骨桥蛋白质 缺氧 RNA干扰 Breast neoplasms Osteopontin Anoxia RNA interference
  • 相关文献

参考文献3

二级参考文献25

  • 1Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 1996, 379: 88-91.
  • 2Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys, 1997, 38 : 285-289.
  • 3Hockel M, Schlenger K, Arad D, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res, 1996, 56: 4509-4515.
  • 4Yang DJ, Wallace S, Cherif A, et al. Development of ^18F-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology, 1995, 194: 795-800.
  • 5Gronroos T, Bentzen L, Marjamaki P, et al. Comparison of the biodistribution of two hypoxia markers [^18F]FETNIM and ^18F-FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging, 2004, 31: 513-528.
  • 6Rajendran JG, Wilson DC, Conrad EU, et al. [^18F]FMISO and [^18F] FDG PET imaging in soft tissue sarcomas : correlation of hypoxia, metabohsm and VEGF expression. Eur J Nucl Med Mol Imaging, 2003, 30: 695 -704.
  • 7Rasey JS, Casciari JJ, Hofstrand PD, et al. Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole. Radiat Res, 2000, 153 : 84-92.
  • 8Lehtio K, Oikonen V, Gronroos T, et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [ ^15O] H(2) O and [ ^18F] fluoroerythronitroimidazole PET. J Nucl Med, 2001, 42: 1643-1652.
  • 9Citron M L,Berry D A,Cirrincione C et al.Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 974[J].J Clin Oncol,2003,21 (8):1431-1439.
  • 10Hong L,Hunt M,Chui C,et al.Intensity-modulated tangential beam irradiation of the intact breast[J].Int J Radiat Oncol Biol Phys,1999,44(5):1155-1164.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部